Medscape Medical News
- Alert FDA Approves First AI Device to Detect Colon Lesions
- Alert FDA Clears Nonstimulant for ADHD in Kids 6 Years and Up
- Alert FDA Okays New Indication for Alirocumab in Homozygous FH
- FDA Approves Myrbetriq to Treat Pediatric NDO
- Alert First CAR T-Cell Therapy for Multiple Myeloma: Abecma
- Alert FDA OKs Transcatheter Pulmonary Valve for Congenital Heart Disease
- Alert FDA OKs Neuromodulation Device to Improve Gait in MS
- Alert Arcalyst Gets FDA Nod as First Therapy for Recurrent Pericarditis
- Alert FDA Approves New Ready-to-Inject Glucagon Product
- Alert FDA Clears Ponesimod (Ponvory), New Oral Drug for MS
- Alert FDA OKs Novel Dual-Action Stimulant Med for ADHD
- Alert FDA Authorizes First Molecular At-Home, OTC COVID-19 Test
- Alert Tocilizumab Scores FDA Approval for SSc-ILD
- Alert Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
- Alert FDA Clears Neuromodulation Device for Acute Migraine Pain
- Alert FDA Grants Emergency Use to Johnson & Johnson COVID-19 Vaccine
- FDA Clears Device to Protect Kids Against Head Injury
- Alert FDA OKs First 'Targeted Treatment' for Rare DMD Mutation
- Alert FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression
- Alert FDA Expands Sacubitril/Valsartan Indication to Embrace Some HFpEF